FOR IMMEDIATE RELEASE
Catheter Precision Announces Appointment of Philip Anderson as Chief Financial Officer
January 7, 2025
FORT MILL, SC / ACCESSWIRE / January 7, 2025 / Catheter Precision, Inc. (NYSE American: VTAK), a pioneering medical device company focused on electrophysiology products, is pleased to announce the appointment of Philip Anderson as its new Chief Financial Officer. Margrit Thomassen, who has been serving as Interim Chief Financial Officer, will continue with the company in the role of Controller.
Appointment of Philip Anderson
In a statement regarding the appointment, David Jenkins, CEO of Catheter Precision, commented: "After conducting an extensive search for the right candidate, we are thrilled to welcome Phil Anderson to our team. His impressive background, which includes executive management across various industries, managing hedge funds at the partner level, and an early stint in investment banking, makes him an ideal fit for our company."
About Philip Anderson
Commenting on his new position with Catheter Precision, Mr. Anderson expressed: "I am honored to join the team at this innovative medical device company. Several factors drew me to this decision, including:
- The exciting market of cardiac electrophysiology, which has experienced tremendous growth.
- The management team in place today is remarkable, with David Jenkins being an entrepreneur and having successfully led three startups in the field.
- Marie-Claude Jacques’s impressive background in heading up US sales at Baylis and subsequently serving as Vice President at Boston Scientific, Inc., within their cardiac electrophysiology division.
- The company’s two products, which are in the beginning of the revenue cycle, have strong clinical evidence behind them.
- My skills align directly with this company at this stage, both on the finance side as well as the operational side."
Inducement Award
As part of his employment agreement, Mr. Anderson received an award of options to purchase 500,000 shares of Company common stock. These options were granted pursuant to Section 711(a) of the NYSE American listed company manual, which allows for qualifying inducement awards to be made without shareholder approval.
About Catheter Precision
Catheter Precision is a U.S.-based innovative medical device company that specializes in developing groundbreaking technology for electrophysiology procedures. The company collaborates with physicians and continuously advances its products to improve the treatment of cardiac arrhythmias.
Contact Information
To learn more about Catheter Precision’s latest developments or to inquire about investment opportunities, please contact:
David Jenkins
973-691-2000
IR@catheterprecision.com
Missiaen Huck
COO
mhuck@catheterprecision.com
9736912000
SOURCE: Catheter Precision, Inc.
Catheter Precision’s appointment of Philip Anderson as Chief Financial Officer marks an exciting new chapter in the company’s journey. With his extensive experience and impressive background, Mr. Anderson is well-positioned to contribute significantly to the company’s continued growth and success.
About Catheter Precision
- Company Overview: Catheter Precision is a U.S.-based innovative medical device company that specializes in developing groundbreaking technology for electrophysiology procedures.
- Product Portfolio: The company has two products in the beginning of the revenue cycle, both of which have strong clinical evidence behind them.
- Market Opportunity: The market of cardiac electrophysiology has experienced tremendous growth, presenting a significant opportunity for Catheter Precision to expand its presence.
Recent Developments
- Appointment of Chief Financial Officer: Philip Anderson joins Catheter Precision as the new Chief Financial Officer, bringing with him extensive experience in executive management and investment banking.
- Inducement Award: As part of his employment agreement, Mr. Anderson received an award of options to purchase 500,000 shares of Company common stock.
Investor Relations
For more information about Catheter Precision’s latest developments or to inquire about investment opportunities, please contact:
David Jenkins
973-691-2000
IR@catheterprecision.com
Missiaen Huck
COO
mhuck@catheterprecision.com
9736912000
SOURCE: Catheter Precision, Inc.
